ARYA Sciences Acquisition Corp. III (ARYA) to Combine with Nautilus Biotechnology in $905M Deal
ARYA Sciences Acquisition Corp. III (Nasdaq:ARYA) has entered into a definitive agreement to combine with Nautilus Biotechnology, Inc. for an enterprise value of $905 million. Nautilus is working to create a machine-learning technology platform for testing and mapping proteins and serve as an accelerant in biopharmaceutical research. The combined entity is expected to trade on
Read More